94 results
Page 3 of 5
8-K
EX-99.1
gu9pw8mfk k4skhdv
15 Mar 22
Gamida Cell Reports Fourth Quarter and Full Year 2021 Financial Results
7:31am
8-K
EX-99.1
gnht1bnf4 ef0kbwvb0
31 Jan 22
Gamida Cell Provides Key Program Updates and 2022 Financial Guidance
9:00am
6-K
EX-99.1
87ohr5iy8y48
15 Nov 21
Gamida Cell Reports Third Quarter 2021 Financial Results
7:29am
6-K
EX-99.1
zdyo3k
26 Oct 21
Gamida Cell to Present NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline and Update on GDA-201 at Today’s Virtual R&D Day
7:30am
6-K
EX-99.1
6pepep
12 Oct 21
Report of Foreign Private Issuer
4:32pm
F-3
EX-1.2
t5tqdeomie9ui58e8xc
13 Sep 21
Shelf registration (foreign)
12:00am
6-K
EX-99.1
ie1dsgr
13 Aug 21
Report of Foreign Private Issuer
4:04pm
6-K
EX-99.1
cn0l0ctyrpyd r4otni7
11 May 21
Gamida Cell Reports First Quarter 2021 Financial Results and Provides Company Update
8:28am
6-K
EX-99.1
k2r0pkrls 5w
9 Mar 21
Gamida Cell Reports Full Year 2020 Financial Results and Provides Company Update
4:08pm
6-K
EX-4.1
4gfg2 sdapb9zgo042
16 Feb 21
Gamida Cell Announces $75 Million Financing with Highbridge Capital Management
8:57am
6-K
EX-99.1
f0m 8lxklfvzo45cr
16 Feb 21
Gamida Cell Announces $75 Million Financing with Highbridge Capital Management
8:57am
6-K
EX-99.1
xim75c19br8bk5075q09
14 Dec 20
Gamida Cell Provides Regulatory Update
4:14pm
6-K
EX-99.1
fognzg9l zbmp8q
9 Dec 20
Report of Foreign Private Issuer
3:37pm
6-K
EX-99.1
b9hefvs7j fcup
8 Dec 20
Gamida Cell Presents Updated, Expanded Results from Phase 1 Study of Natural Killer Cell Therapy GDA-201 at ASH Annual Meeting and Exposition
3:19pm
6-K
EX-99.1
crlvylw3uvjg
10 Nov 20
Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update
8:23am
6-K
EX-99.1
n1fjbrb0eg47
5 Nov 20
Gamida Cell Announces Data to Be Presented at 62nd ASH Annual Virtual Meeting
10:36am
6-K
EX-99.3
fwxrckq
12 Aug 20
Report of Foreign Private Issuer
8:27am
6-K
EX-99.1
avjmu6m1 09oxju3t
6 Aug 20
Report of Foreign Private Issuer
4:02pm